Advertisement

Systemic and Dismetabolic Disorders

  • Francesco Brigo
  • Oriano Mecarelli
Chapter

Abstract

Several systemic or metabolic disorders may cause an impairment of cerebral functions. Neuroimaging investigations are often not sensitive enough to appropriately evaluate these clinical conditions. The EEG represents therefore a useful method for assessing brain functional activity, to support clinical diagnosis and to monitor follow-up (neuromonitoring). In systemic and metabolic disorders, EEG changes reflect the diffuse cerebral impairment and may detect negative prognostic factors. Widespread EEG slowing sometimes associated with epileptiform activity is a typical pattern encountered in these conditions; however it is neither pathognomonic nor specific of a certain etiology. EEG can also demonstrate the improvement of cerebral function following therapy of the underlying disorder.

Keywords

Acute porphyria Cardiorespiratory disease Disorders of glucose metabolism Eclampsia Electrolyte disturbances Liver disease Renal disease Thyroid and hormonal disorders 

References

  1. 1.
    Kaplan PW. The EEG in metabolic encephalopathy and coma. J Clin Neurophysiol. 2004;21:307–18.CrossRefGoogle Scholar
  2. 2.
    Sutter R, Pang T, Kaplan PW. EEG in metabolic disorders, intoxications, and epileptic encephalopathies. In: Schomer DL, Lopes da Silva F, editors. Niedermeyer’s electroencephalography: basic principles, clinical applications, and related fields. 7th ed. New York, NY: Oxford University Press; 2018. p. 433–66.Google Scholar
  3. 3.
    Conn HO, Leevy CM, Vlahecevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double-blind controlled trial. Gastroenterology. 1977;72:573–83.PubMedGoogle Scholar
  4. 4.
    Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–35.CrossRefGoogle Scholar
  5. 5.
    Brigo F. Intermittent rhythmic delta activity patterns. Epilepsy Behav. 2011;20:254–6.CrossRefGoogle Scholar
  6. 6.
    Brigo F, Storti M. Triphasic waves. Am J Electroneurodiagnostic Technol. 2011;51:16–25.CrossRefGoogle Scholar
  7. 7.
    Parsons-Smith BG, Summerrsskill WHJ, Dawson AM, Sherlock S. The electroencephalogram in liver disease. Lancet. 1957;2:867–71.CrossRefGoogle Scholar
  8. 8.
    Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, Zuliani C, Campo G, Gatta A, Guerit JM. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol. 1999;110:1334–44.CrossRefGoogle Scholar
  9. 9.
    Van der Rijt CD, Schalm SW, De Groot GH, De Vlieger M. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr Clin Neurophysiol. 1984;57:423–6.CrossRefGoogle Scholar
  10. 10.
    Amodio P, Gatta A. Neurophysiological investigation of hepatic encephalopathy. Metab Brain Dis. 2005;20:369–79.CrossRefGoogle Scholar
  11. 11.
    Amodio P, Pellegrini A, Ubiali E, Mathy I, Del Piccolo F, Orsato R, Gatta A, Guerit JM. The EEG assessment of low-grade hepatic encephalopathy: comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clin Neurophysiol. 2006;117:2243–51.CrossRefGoogle Scholar
  12. 12.
    Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, Ubiali E, Amodio P, members of the ISHEN commission on Neurophysiological Investigations. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29:789–96.CrossRefGoogle Scholar
  13. 13.
    Ciancio A, Marchet A, Saracco G, Carucci P, Lavezzo B, Leotta D, Capellero B, Nobili M, Smedile A, Rizzetto M. Spectral electroencephalogram analysis in hepatic encephalopathy and liver transplantation. Liver Transpl. 2002;8:630–5.CrossRefGoogle Scholar
  14. 14.
    Yamada T, Young S, Kimura J. Significance of positive spike bursts in Reye’s syndrome. Arch Neurol. 1977;34:376–80.CrossRefGoogle Scholar
  15. 15.
    Hughes JR. EEG in uremia. Am J EEG Technol. 1984;24:1–10.CrossRefGoogle Scholar
  16. 16.
    Scollo-Lavizzari G, Bassetti C. Prognostic value of EEG in post-anoxic coma after cardiac arrest. Eur Neurol. 1987;26:161–70.CrossRefGoogle Scholar
  17. 17.
    Nardone R, Brigo F, Trinka E. Acute symptomatic seizures caused by electrolyte disturbances. J Clin Neurol. 2016;12:21–33.CrossRefGoogle Scholar
  18. 18.
    Mocellin R, Walterfang M, Velakoulis D. Hashimoto’s encephalopathy: epidemiology, pathogenesis and management. CNS Drugs. 2007;21:799–811.CrossRefGoogle Scholar
  19. 19.
    Arain A, Abou-Khalil B, Moses H. Hashimoto’s encephalopathy: documentation of mesial temporal seizure origin by ictal EEG. Seizure. 2001;10:438–41.PubMedGoogle Scholar
  20. 20.
    Thomas SV, Somanathan N, Radhakumari R. Interictal EEG changes in eclampsia. Electroencephalogr Clin Neurophysiol. 1995;94:271–5.CrossRefGoogle Scholar
  21. 21.
    Reichenmiller HE. EEG findings in acute porphyria. Electroencephalogr Clin Neurophysiol. 1970;29:214–5.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Francesco Brigo
    • 1
    • 2
  • Oriano Mecarelli
    • 3
  1. 1.Department of Neurosciences, Biomedicine and Movement SciencesUniversity of VeronaVeronaItaly
  2. 2.Department of NeurologyHospital Franz TappeinerMeranoItaly
  3. 3.Department of Human NeurosciencesSapienza University of RomeRomeItaly

Personalised recommendations